Experience with heat shock protein-peptide complex 96 vaccine therapy in patients with indolent non-hodgkin lymphomaOKI, Yasuhiro; MCLAUGHLIN, Peter; FAYAD, Luis E et al.Cancer. 2007, Vol 109, Num 1, pp 77-83, issn 0008-543X, 7 p.Article

Indolent lymphoma: the pathologist's viewpointPILERI, S. A; ZINZANI, P. L; WENT, P et al.Annals of oncology. 2004, Vol 15, Num 1, pp 12-18, issn 0923-7534, 7 p.Article

High-dose therapy and autologous stem-cell transplantation can improve event-free survival for indolent lymphoma : A study using patients as their own controlsVIGNOT, Stéphane; MOUNIER, Nicolas; LARGHERO, Jérome et al.Cancer. 2007, Vol 109, Num 1, pp 60-67, issn 0008-543X, 8 p.Conference Paper

Low dose 2-CdA schedule activity in Splenic Marginal Zone LymphomasRICCIONI, R; CARACCIOLO, F; GALIMBERTI, S et al.Hematological oncology. 2003, Vol 21, Num 4, pp 163-168, issn 0278-0232, 6 p.Article

Management of indolent lymphoma: Where are we now and where are we goingLUNNING, Matthew A; VOSE, Julie M.Blood reviews. 2012, Vol 26, Num 6, pp 279-288, issn 0268-960X, 10 p.Article

Transformation of Indolent B-Cell LymphomasMONTOTO, Silvia; FITZGIBBON, Jude.Journal of clinical oncology. 2011, Vol 29, Num 14, pp 1827-1834, issn 0732-183X, 8 p.Article

Advances in molecular biology diagnostic and treatment of B-cell malignancies : indolent B-cell lymphomaDREYLING, M; BUSKE, C; HIDDEMANN, W et al.Annals of oncology. 2005, Vol 16, pp ii99-ii104, issn 0923-7534, SUP2Conference Paper

The peripheral helper T-cell repertoire in untreated indolent B-cell lymphomas : evidence for antigen-driven lymphomagenesisCHRISTOPOULOS, P; FOLIO, M; FISCH, P et al.Leukemia. 2008, Vol 22, Num 10, pp 1952-1954, issn 0887-6924, 3 p.Article

Durable response but prolonged cytopenia after cladribine treatment in relapsed patients with indolent non-Hodgkin's lymphomas: Results of a Japanese phase II studyOGURA, Michinori; MORISHIMA, Yasuo; NAKAMURA, Shigeo et al.International journal of hematology. 2004, Vol 80, Num 3, pp 267-277, issn 0925-5710, 11 p.Article

Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana LinfomiARCAINI, L; VALLISA, D; TUCCI, A et al.Annals of oncology. 2014, Vol 25, Num 7, pp 1404-1410, issn 0923-7534, 7 p.Article

Thalidomide has limited single-agent activity in relapsed or refractory indolent non-Hodgkin lymphomas : a phase II trial of the Cancer and Leukemia Group BSMITH, Sonali M; GRINBLATT, David; JOHNSON, Jeffrey L et al.British journal of haematology. 2008, Vol 140, Num 3, pp 313-319, issn 0007-1048, 7 p.Article

Reduced-intensity hematopoietic stem-cell transplantation for malignant lymphoma : a retrospective survey of 112 adult patients in JapanKUSUMI, E; KAMI, M; TAMAKI, T et al.Bone marrow transplantation (Basingstoke). 2005, Vol 36, Num 3, pp 205-213, issn 0268-3369, 9 p.Article

Fludarabine, mitoxantrone and dexamethasone in the treatment of indolent B- and T-cell lymphoid malignancies in Chinese patientsMA, Shing Y; AU, Wing Y; CHIM, Chor S et al.British journal of haematology. 2004, Vol 124, Num 6, pp 754-761, issn 0007-1048, 8 p.Article

Results of a phase 2 study of bortezomib in patients with relapsed or refractory indolent lymphomaDI BELLA, Nicholas; TAETLE, Raymond; VUKELJA, Svetislava J et al.Blood. 2010, Vol 115, Num 3, pp 475-480, issn 0006-4971, 6 p.Article

Phase II trial of idiotype vaccination in previously treated patients with indolent non-hodgkin's lymphoma resulting in durable clinical responsesREDFERN, Charles H; GUTHRIE, Troy H; ROSENFELT, Fred P et al.Journal of clinical oncology. 2006, Vol 24, Num 19, pp 3107-3112, issn 0732-183X, 6 p.Article

Rituximab in Indolent LymphomasSOUSOU, Tarek; FRIEDBERG, Jonathan.Seminars in hematology. 2010, Vol 47, Num 2, pp 133-142, issn 0037-1963, 10 p.Article

Antibody and Immunomodulatory Agents in the Treatment of Indolent Non-Hodgkin's LymphomaLACASCE, Ann S; FREEDMAN, Arnold S.Seminars in hematology. 2008, Vol 45, Num 2, pp 85-89, issn 0037-1963, 5 p.Article

An aggressive extranodal NK-cell lymphoma arising from indolent NK-cell lymphoproliferative disorderQIN HUANG; CHANG, Karen L; GAAL, Karl K et al.The American journal of surgical pathology. 2005, Vol 29, Num 11, pp 1540-1543, issn 0147-5185, 4 p.Article

Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissueZUCCA, Emanuele; CONCONI, Annarita; GIARDINI, Roberto et al.Blood. 2003, Vol 101, Num 7, pp 2489-2495, issn 0006-4971, 7 p.Article

Serum nm23-H1 protein as a prognostic factor for indolent non-hodgkin's lymphomaNIITSU, N; OKAMOTO, M; OKABE-KADO, J et al.Leukemia. 2001, Vol 15, Num 5, pp 832-839, issn 0887-6924Article

Stem cell transplantation for indolent lymphoma A reappraisalVAN BESIEN, Koen.Blood reviews. 2011, Vol 25, Num 5, pp 223-228, issn 0268-960X, 6 p.Article

Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemiaGOLDIN, Lynn R; BJÖRKHOLM, Magnus; KRISTINSSON, Sigurdur Y et al.Haematologica (Roma). 2009, Vol 94, Num 5, pp 647-653, issn 0390-6078, 7 p.Article

Japanese phase II study of ⁹⁰Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphomaTOBINAI, Kensei; WATANABE, Takashi; OKUMURA, Hirokazu et al.Cancer science. 2009, Vol 100, Num 1, pp 158-164, issn 1347-9032, 7 p.Article

Lenalidomide Oral Monotherapy Produces Durable Responses in Relapsed or Refractory Indolent Non-Hodgkin's LymphomaWITZIG, Thomas E; WIERNIK, Peter H; ERVIN-HAYNES, Annette et al.Journal of clinical oncology. 2009, Vol 27, Num 32, pp 5404-5409, issn 0732-183X, 6 p.Article

Secondary malignancies after therapy of indolent non-Hodgkin's lymphomaFRIEDBERG, Jonathan W.Haematologica (Roma). 2008, Vol 93, Num 3, pp 336-338, issn 0390-6078, 3 p.Article